OpenCell

OpenCell Technologies Appoints Biotech Veteran Dr. Behzad Mahdavi as Executive Chairman of the Board of Directors

Retrieved on: 
Tuesday, October 31, 2023
OpenCell, Doctor of Philosophy, MBA, Cell, Transfection, ST, Growth, Synthetic biology, Chemistry, Fine chemical, Management

ST. LOUIS, Oct. 31, 2023 /PRNewswire/ -- OpenCell Technologies, a leader in pioneering the development and commercialization of next generation cellular transfection technologies, is pleased to announce the appointment of Behzad Mahdavi, Ph.D., MBA, as Executive Chairman of the Board of Directors.

Key Points: 
  • ST. LOUIS, Oct. 31, 2023 /PRNewswire/ -- OpenCell Technologies , a leader in pioneering the development and commercialization of next generation cellular transfection technologies, is pleased to announce the appointment of Behzad Mahdavi, Ph.D., MBA , as Executive Chairman of the Board of Directors.
  • In addition to his industry leadership roles, Dr. Mahdavi has made significant contributions as a member of multiple Boards of Directors and Advisory Boards.
  • "We are delighted to welcome Dr. Mahdavi as an experienced Board member and Chairman with exceptional business and technical expertise to support technology commercialization and global business growth," said OpenCell investor and Board member, Dr. Chad Stiening.
  • I am excited to support the Opencell team in bringing this groundbreaking technology to the market," said Dr. Mahdavi.

Chan Zuckerberg Science To Build AI GPU Cluster To Model Cell Systems

Retrieved on: 
Tuesday, September 19, 2023
Graphics processing unit, Infection, Science, LLM, Partnership, Harvard University, Chan Zuckerberg Biohub, ESM, OpenCell, ChatGPT, Intelligence, Research, Multimedia, Cell, MIT Technology Review, Organization, Nature, Chan Zuckerberg Initiative, CZ, Entrepreneurship, Investment, Child, HPC, Artificial intelligence, Biology, Knowledge, AI, Health, AlphaFold, CZI, Genome, GPU, Disease, Pharmaceutical industry, Mobile phone, Management

REDWOOD CITY, Calif., Sept. 19, 2023 /PRNewswire/ -- Today, the Chan Zuckerberg Initiative announced the funding and building of one of the largest computing systems dedicated to nonprofit life science research in the world. This new effort will provide the scientific community with access to predictive models of healthy and diseased cells, which will lead to groundbreaking new discoveries that could help cure, prevent, or manage all diseases by the end of this century. The high-performance computing cluster, which is planned to comprise 1,000+ GPUs, will enable AI and large language models for biomedicine at scale.

Key Points: 
  • The high-performance computing cluster, which is planned to comprise 1,000+ GPUs, will enable AI and large language models for biomedicine at scale.
  • "AI is creating new opportunities in biomedicine, and building a high-performance computing cluster dedicated to life science research will accelerate progress on important scientific questions about how our cells work," said CZI Co-founder and Co-CEO Mark Zuckerberg.
  • AI systems such as AlphaFold and ESM have already made significant contributions to studying human biology.
  • CZ Science has employed many AI tools in its research for years, and this focus will unify our collective efforts to create a field-wide resource for better understanding cells and cell systems."

British High Commissioner Dr. Christian Turner Inaugurates Robot-Operated Covid-19 Testing Lab in Islamabad

Retrieved on: 
Sunday, November 15, 2020
Biological hazards, Safety, Articles, OpenCell, Euthenics, Biosafety level, ISO 15189, Ethics, Biosafety, Laboratory, Siddiqui

Built in the United Kingdom by Opencell UK, the laboratory is a Biosafety Level 2 plus (BSL-2+) facility built to ISO 15189 standards.

Key Points: 
  • Built in the United Kingdom by Opencell UK, the laboratory is a Biosafety Level 2 plus (BSL-2+) facility built to ISO 15189 standards.
  • The state-of-art lab is specified to meet the requirements for high throughput Covid-19 RT-qPCR testing.
  • Due to the use of 5 liquid handling robots, this lab requires as little as 6 staff members to operate all the shifts.
  • While speaking at the event, High Commissioner Dr. Christian Turner thanked Ambassador Ali Jehangir Siddiqui for "making him excited about the project.

OpenCell Partners with King’s College and Opentrons To Create Affordable Shipping Container COVID-19 Testing Lab

Retrieved on: 
Thursday, May 21, 2020
Other Health, Software, General Health, Hardware, Data management, Medical devices, Technology, Infectious diseases, Clinical trials, Biotechnology, Other Technology, Health, Software testing, Automation, Test automation, Engineering, OpenCell, Opentrons Labworks

Scientists from OpenCell.bio and King's College London, in partnership with Opentrons Labworks, have developed a low-cost rapidly deployable COVID testing lab inside a shipping container that can process 2,400 tests per day.

Key Points: 
  • Scientists from OpenCell.bio and King's College London, in partnership with Opentrons Labworks, have developed a low-cost rapidly deployable COVID testing lab inside a shipping container that can process 2,400 tests per day.
  • View the full release here: https://www.businesswire.com/news/home/20200521005069/en/
    This is the first fully functional lab that can be immediately deployed anywhere in the world for COVID testing.
  • Given Opentrons ability to rapidly deploy lab automation, and the shipping container form factor of this testing lab, this system is ready to be sent wherever automated testing bandwidth is needed.
  • With its easy-to-use hardware and an open software platform, Opentrons automates manual lab work and empowers collaborative research for life scientists.